National Science Foundation (NSF) funding will help BIO5 member Pierre Deymier and other researchers establish a new center at the University of Arizona that seeks to exploit the properties of sound in ways that could vastly improve computing, telecommunications and sensing.

The SensorLab is a UArizona Health Sciences strategic initiative with several BIO5 members that serves as a hub to bring students, faculty, industry and community partners together to encourage creativity and innovation in research and education by providing access to sensor technology and expertise.

Mentorship with University of Arizona researchers helps these promising Arizona high school students explore their passion of scientific discovery.

Research at Biosphere 2 uncovers how soil microbes process carbon and interact with the atmosphere under environmental stress. Learn about a study by BIO5 members Laura Meredith and Malak Tfaily that helps scientists predict and support how ecosystems will adapt in the face of increasing temperatures and prolonged drought.

Now in it's sixth year, this internship program is a unique opportunity for UArizona undergraduate students to work on the business and marketing aspects of a research institution.

Nature-loving BIO5 member Frank von Hippel says the melting permafrost and changing growing season are signs of the need for the One Health initiative.

BIO5 members Clara Curiel and Nirav Merchant are part of a team of researchers filling a knowledge gap by building a powerful tool to accelerate the development of diagnostic and prognostic technologies.

Funding from the National Institutes of Health helped the University of Arizona be among the first institutions in the country to receive a new MRI system that can produce clearer and more comprehensive brain images. BIO5 member Ted Trouard developed the grant proposal in partnership with the BIO5 Institute.

Curiosity guides BIO5 member Marvin Slepian to bridge medicine, engineering and now the law to address unmet needs in research and mentorship.

BIO5 member Roberta Diaz Brinton and her team are investigating the long-term safety and efficacy of allopregnanolone as a regenerative therapeutic for Alzheimer's disease and cerebral palsy.